Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bovie Medical Corp (BVX)

Bovie Medical Corp (BVX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 215,136
  • Shares Outstanding, K 33,200
  • Annual Sales, $ 38,880 K
  • Annual Income, $ -5,060 K
  • 60-Month Beta -0.27
  • Price/Sales 5.47
  • Price/Cash Flow N/A
  • Price/Book 2.36
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings -0.01 on 11/01/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.10
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.89 +32.52%
on 12/20/18
7.70 -15.84%
on 12/11/18
-0.59 (-8.35%)
since 11/30/18
3-Month
4.82 +34.44%
on 10/23/18
7.70 -15.84%
on 12/11/18
-0.62 (-8.73%)
since 09/28/18
52-Week
2.28 +184.21%
on 03/12/18
7.70 -15.84%
on 12/11/18
+3.88 (+149.23%)
since 12/29/17

Most Recent Stories

More News
NOTICE For Investors In NASDAQ: APYX Shares: Update in Lawsuit against Apyx Medical Corporation announced by Shareholders Foundation

San Diego, California--(Newsfile Corp. - June 16, 2020) - The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Apyx Medical Corporation (NASDAQ: APYX) shares....

BVX : 6.48 (+1.09%)
APYX : 5.14 (+2.80%)
Global Electrosurgical Devices Market Outlook (2018 to 2027) - Featuring Olympus, Medtronic & Bovie Medical Among Others

The "Electrosurgical Devices - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

BVX : 6.48 (+1.09%)
Insights into the Global Electrosurgical Devices Industry to 2027 - Drivers, Restraints, Opportunities & Threats

, /PRNewswire/ -- The report has been added to offering.

BVX : 6.48 (+1.09%)
CNMD : 85.88 (+1.07%)
MDT : 100.38 (+0.33%)
OCPNY : 19.1010 (+0.53%)
SNN : 40.90 (-2.20%)
APYX Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm; Should Management be Held Accountable for Investors' Losses?

Johnson Fistel, LLP is investigating potential claims on behalf of Apyx Medical Corporation (formerly Bovie Medical) ("Apyx" or the "Company") (NASDAQ: APYX) against certain of its officers and directors....

BVX : 6.48 (+1.09%)
APYX : 5.14 (+2.80%)
Apyx Medical Corporation Announces Subject Enrollment Initiated in New Study Evaluating the Use of Renuvion(R) Technology in Dermal Resurfacing Procedures

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold...

BVX : 6.48 (+1.09%)
APYX : 5.14 (+2.80%)
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold...

BVX : 6.48 (+1.09%)
APYX : 5.14 (+2.80%)
Apyx Medical Corporation Announces Subject Enrollment Initiated in Study Evaluating the Use of Renuvion(R) Technology in Skin Laxity Procedures in the Neck and Submental Region

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold...

BVX : 6.48 (+1.09%)
APYX : 5.14 (+2.80%)
Apyx Medical Corporation Receives 510(k) Clearance for the Apyx Plasma/RF Handpiece

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold...

BVX : 6.48 (+1.09%)
APYX : 5.14 (+2.80%)
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in September and October

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold...

BVX : 6.48 (+1.09%)
APYX : 5.14 (+2.80%)
Apyx Medical Corporation Announces Appointment of Minnie Baylor-Henry to the Company's Board of Directors

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold...

BVX : 6.48 (+1.09%)
APYX : 5.14 (+2.80%)
Trade BVX with:

Business Summary

Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devicesand advanced coating technologies.

See More

Key Turning Points

2nd Resistance Point 6.87
1st Resistance Point 6.68
Last Price 6.48
1st Support Level 6.32
2nd Support Level 6.15

See More

52-Week High 7.70
Last Price 6.48
Fibonacci 61.8% 5.63
Fibonacci 50% 4.99
Fibonacci 38.2% 4.35
52-Week Low 2.28

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar